Overexpression of Krüppel-Like Factor 4 Suppresses Migration and Invasion of Non-Small Cell Lung Cancer Through C-Jun-NH2-Terminal Kinase/Epithelial-Mesenchymal Transition Signaling Pathway
Overview
Authors
Affiliations
Krüppel-like factor 4 (KLF4) is a transcription factor and plays a vital role in cancer initiation and development. However, the role of Krüppel-like factor 4 in the metastasis of non-small cell lung cancer (NSCLC) is not clear. Here, we demonstrated that the expression of Krüppel-like factor 4 was significantly decreased in human non-small cell lung cancer tissues compared with that in normal tissues using Western blot. We performed immunohistochemical staining and observed the decreased expression of Krüppel-like factor 4 in human lung cancer tissues, and metastatic tumor tissues located in the trachea and main bronchus. We also found that the E-cadherin expression was decreased, while vimentin expression was increased in human NSCLC tissues and metastatic tumor tissues located in the trachea and main bronchus. Additionally, enforced expression of Krüppel-like factor 4 in mouse lungs significantly inhibited the metastasis of circulating Lewis lung carcinoma cells to the lungs by attenuating mesenchymal-epithelial transition (MET). Furthermore, cell scratch assays and Matrigel invasion assays revealed that overexpression of Krüppel-like factor 4 inhibited the migration and invasion of non-small cell lung cancer cell lines A549, H1299, H226, and H1650 cells. Moreover, overexpression of Krüppel-like factor 4 attenuated TGF-β1-induced epithelial-mesenchymal transition (EMT) in A549, and inhibited the phosphorylation of c-Jun-NH2-terminal kinase (JNK), an important pathway in metastasis in non-small cell lung cancer. Our and findings illustrate that Krüppel-like factor 4 inhibited metastasis and migration of non-small cell lung cancer, and indicate that Krüppel-like factor 4 could be a potential therapeutic target for the treatment of non-small cell lung cancer.
Exosomal miR-146a-5p Derived from HSCs Accelerates Sepsis-induced Liver Injury by Suppressing KLF-4.
Sheng Z, Song H, Gao X, Shu B, You Y, Liu Z Inflammation. 2024; .
PMID: 39589633 DOI: 10.1007/s10753-024-02172-6.
Sun P, Xia S, Yuan R, Zhang B, Wang G Cancers (Basel). 2024; 16(13).
PMID: 39001509 PMC: 11240709. DOI: 10.3390/cancers16132447.
Du M, Meng X, Zhou B, Song W, Shi J, Liang M J Cell Mol Med. 2024; 28(12):e18387.
PMID: 38924680 PMC: 11200130. DOI: 10.1111/jcmm.18387.
Research Progress of Plant-Derived Natural Products against Drug-Resistant Cancer.
Liu W, Wang Y, Xia L, Li J Nutrients. 2024; 16(6).
PMID: 38542707 PMC: 10975298. DOI: 10.3390/nu16060797.
Wei S, Qi F, Wu Y, Liu X Int J Mol Sci. 2023; 24(18).
PMID: 37762310 PMC: 10530972. DOI: 10.3390/ijms241814008.